[1] Gupta N,Gupta T,Asthana D.Prediction of Preeclampsia in Early Pregnancy by Estimating the Spot Urinary Albumin /Creati-nine Ratio[J].J Obstet Gynaecol India,2017,67(4): 258-262.
[2] Boeldt DS, Bird IM.Vascularadaptationin pregnancy and endothelial dysfunction in preeclampsia[J]. JEndocrinol, 2017, 232(1): 27-44.
[3] Feitosa ACR, Barreto LT, Silva IMD, et al.Impact of the use of different diagnostic criteria in the prevalence of dyslipidemia in pregnant women[J]. Arq Bras Cardiol, 2017, 109(1): 30-38.
[4] Smedts HP.A derangement of the maternal lipid profile is associated with an elevated risk of congenital heart disease in the offspring[J]. Nutr Metab Cardiovase Dis,2012,22(6): 477-485.
[5] 蒋红清,陈寒,杨静. 妊娠期血脂水平的特点及其影响因素[J]. 中华医学杂志,2016,96(9): 724-726.
[6] Huang CL,Liu J,Lu YY,et al.Clinical features and treatment of hypertriglyceridemia-induced acute pancreatitis during pregnancy: A retrospective study[J]. J Clin Apheresis,2016,31(7): 571-578.
[7] Ghodke B,Pusukuru R,Mehta V.Association of lipid profile in pregnancy with preeclampsia,gestational diabetes mellitus,and preterm delivery[J]. Cureus,2017,9(7): e1420.
[8] Jiang S,Jiang J,Xu H,et al.Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: A meta-analysis[J]. Taiwan J Obestet Gynecol,2017,56(1): 9-15.
[9] Gunderson EP,Lewis CE,Murtaugh MA,et al.Long-term plasma lipid changes associated with a first birth[J]. Am J Epidemiol,2004,159(11): 1028-1039.
[10] Feitosa ACR,Barreto LT,Silva IMD,et al.Impatc of the use of different diagnostic criteria in the prevalence of dyslipidemia in pregnant women[J]. Arquivos Brasileiros de Cardiologia,2017, 109(1): 30-38.
[11] Mahmood O.Metformin versus insulin in the management of gestational diabetes mellitus[J]. Medical Journal of Babylon,2019,16(4): 346-350.
[12] Liang Z,Wu Y,Zhu X,et al.Insulin resistance and lipid profile during an oral glucose tolerance test in women with and without gestational diabetes mellitus[J]. J Obstet Gynecol,2016,36: 337-339.
[13] Barat S,Ghanbarpour A,Bouzari Z,et al.Triglyceride to HDL cholesterol ratio and risk for gestational diabetes and birth of a large-for-gestational-age newborn[J]. Caspian J Intern Med,2018,9(4): 368-375.
[14] 韩肖燕,杨惠霞,杨烨. 妊娠期糖尿病孕妇晚孕期血脂浓度检测的临床意义[J]. 中华妇幼临床医学杂志(电子版),2019,15(1):14-18.
[15] 周文,彭劭珺,张艳. 妊娠期血脂水平与妊娠期糖尿病及巨大儿分娩率的相关性分析[J]. 当代医学,2019, 25:156-158.
[16] 刘婧,程敬东,周英. 1941例妊娠期糖代谢异常孕妇血脂分析[J]. 中国计划生育和妇产科,2018,(3):50-53.
[17] Marseille-Tremblay C,Ethier-Chiasson M,Forest JC,et al.Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta[J]. Mol Reprod Dev,2008,75(6): 1054-1062.
[18] Rizzo M,Berneis K,Altinova AE,et al.Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes[J]. Diabetic Med,2008,25(12): 1406-1411.
[19] Schiavone M,Putoto G,Laterza F,et al.Gestational diabetes: An overview with attention for developing countries[J]. Endocr Regul, 2016, 50(2): 62-71.
[20] Nermina B,Amina V,Asija Z,et al.The triglyceride/HDL ratio and triglyceride glucose index as predictors of glycemic control in patients with diabetes mellitus type 2[J]. Med Arch,2019,73(3): 163-168.
[21] Barat S,Ghanbarpour A,Bouzari Z,et al.Triglyceride to HDL cholesterol ratio and risk or gestational diabetes and birth of a large-for-gestational-age newborn[J]. Caspian J Int Med,2018,9(4): 368-375.
[22] dos Santos-Weiss ICR,Réa RR,Fadel-Picheth CMT,et al.The plasma logarithm of the triglyceride /HDL-cholesterol ratio is a predictor of low risk gestational diabetes in early pregnancy[J]. Clin Chim Acta,2013,418: 1-4.
[23] Fernandez ML,Webb D.The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk[J]. J Am College Nutr,2008,27(1): 1-5.
[24] Akbas EM,Timuroglu A,Ozcicek A,et al.Association of uric acid,Atherogenic index of plasma and albuminuria in diabetes mellitus[J]. Int J Clin Exp Med,2014,7(12): 5737-5743.
[25] 张文林. 孕中期血脂 LDL-C/HDL-C及TG/HDL-C比值与妊娠期糖尿病的关系[J]. 中国实用医药,2021,(12):49-51.
[26] Johannes V, Ferdinand R, Rebecca Y.Short Term Impact of Physiological Repletion of Estradiol and Progesterone on LDL-C,HDL-C,nonHDL-C,TC,TG,apo B and Lp(a) Concentrations in Postmenopausal Women[J]. Journal of Clinical Lipidology, 2018, 12(2): 558-562.
[27] Zhou X,Han TL, Chen H, et al.Impaired Mitochondrial Fusion, Autophagy, Biogenesis and Dysregulated Lipid Metabolism is associated with Preeclampsia[J]. Experimental Cell Research, 2017, 359(1): 195-200.
[28] Benschop L,Bergen NE,Schalekamp-Timmermans S,et al.Maternal lipid profile 6 years after a gestational hypertensive disorder[J]. J Clin Lipidol,2018,12(2):428-436.
[29] 陈超雄,罗娜,江健,等. 冠心病患者中氧化低密度脂蛋白与血管内皮损伤的关系探讨[J]. 医学理论与实践,2019,32(6):890-891.
[30] 马旭,张琳,沈笑然,等. 心血管疾病患者载脂蛋白E基因型分布及血脂水平初步分析[J]. 临床检验杂志,2019,37(7):528-530.
[31] 宋扬,范雪松,王恩世,等. 血清载脂蛋白 E 水平与颈动脉粥样硬化斑块的关系研究[J]. 检验医学与临床,2020,17(15):2126-2129.
[32] Sahu S,Abraham R,Vedavalli R,et al.Study of lipid profile,lipid peroxidation and vitamin E in pregnancy in duced hypertension[J]. Indian J Physiol Pharmaeol,2009,53(4):365-369.
[33] 周建军,胡娅莉,王志群,等. 妊娠中期母体血脂及尿酸水平对子病前期、妊娠期糖尿病和巨大儿的预测价值[J]. 中华围产医学杂志,2012,15(4):217-221.
[34] Cok T, Tarin F, Bagis T.Is olated abnormal value during the 3-hour glucose tolerance test which value is associated with macrosomia[J]. J Matem Fetal Neonatal Med, 2011, 24(8):1039-1041.
[35] 王冬雪,张硕,万庆宇,等.Gab1在胎盘中的表达与妊娠期糖尿病孕妇新生儿出生体重的关系[J]. 中华围产医学杂志,2016,19(11): 872-877.
[36] 孔令英,杨慧霞,孟文颖,等. 妊娠期血脂与妊娠期糖尿病、巨大儿的关系研究[J]. 中华糖尿病杂志,2016,8(12):735-740.
[37] Carson MP,Ananth CV,Bannerman CG,et al.Postpartum testing to detect persistent dysglycemia in women with gestational diabetes mellitus[J]. Obstet Gynecol,2018,132(1): 193-198.
[38] Bao W,Dar S,Zhu Y,et al.Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus:a longitudianldinal study[J]. J Diabetes,2018,10(6):487-495.
[39] 欧国平,董剑,王柱,等. 糖脂代谢指标与妊娠糖尿病孕妇胰岛素抵抗程度的关系及对巨大儿的预测效能研究[J].中国性科学,2021,30(2):52-55.
[40] Jin HY.Prevalence of subclinical hypothyroidism in obese children or adolescents and association between thyroid hormone and the components of metabolic syndrome[J]. J Paediatr Child Health, 2018, 54(9): 975-980.
[41] 叶文慧,何柳瑜,吕小飞,等. 妊娠早期合并亚临床甲状腺功能减退妇女自身抗体阳性对不良妊娠结局的影响[J]. 实用妇产科杂志,2018,34(1): 34-37.
[42] 杨金光,汪海瑛. 血清apelin、FGF-21与妊娠期合并亚临床甲状腺功能减退症孕妇脂代谢和甲状腺激素的关系[J]. 海南医学,2020,31(17):2218-2221.
[43] 中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南[J]. 中华围产医学杂志, 2012,15(7): 385-403.
[44] 何文慧,李香兰,王晓静. 妊娠期亚临床甲状腺功能减退症对妊娠期糖尿病糖脂代谢的影响[J]. 河北医药,2016, 38(15):2289-2291.
[45] 王巧敏,刘怀昌,李蕊,等. 甲状腺功能减退对妊娠期糖尿病孕妇糖代谢及胰岛素敏感性的影响[J]. 广东医学,2016,37(2):245-246.
[46] 尹进波,周宗爱,汤智越,等. 妊娠合并甲状腺功能减退患者血清apelin、lipocalin-2表达及与血脂关系[J]. 中国计划生育学杂志,2019,27(3): 355-358. |
